miR-145 suppresses cell invasion in hepatocellular carcinoma cells: MiR-145 targets ADAM17

Hepatology Research

Volumn 44, Issue 5, 2014, Pages 551-559

  Yang, Xue wei ^a   Zhang, Long juan ^a   Huang, Xiao hui ^a   Chen, Lian zhou ^a   Su, Qiao ^a   Zeng, Wen tao ^a   Li, Wen ^a   Wang, Qian ^a  

^a THE FIRST AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

ADAM17; Hepatocellular carcinoma; Invasion; MiR 145

Indexed keywords

ADAM PROTEIN; DISINTEGRIN AND METALLOPROTEASE 17; MICRORNA 145; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ADULT; ARTICLE; CANCER CONTROL; CANCER INHIBITION; CANCER STAGING; CARCINOMA CELL; CELL INVASION; CELL INVASION ASSAY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE REPRESSION; GENE SILENCING; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LIVER CELL CARCINOMA; LIVER METASTASIS; LUCIFERASE ASSAY; MALE; PRIORITY JOURNAL; PROTEIN FAMILY; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

EID: 84899101389     PISSN: 13866346     EISSN: 1872034X     Source Type: Journal    
DOI: 10.1111/hepr.12152     Document Type: Article

References (23)

1. Thomas MB, Jaffe D, Choti MM etal. Hepatocellular carcinoma: consensus recommendations of the National Cancer Institute Clinical Trials Planning Meeting. J Clin Oncol 2010; 28: 3994-4005.
2. Kong YW, Ferland-McCollough D, Jackson TJ etal. microRNAs in cancer management. Lancet Oncol 2012; 13: e249-258.
3. Yao J, Liang L, Huang S etal. MicroRNA-30d promotes tumor invasion and metastasis by targeting Galphai2 in hepatocellular carcinoma. Hepatology 2010; 51: 846-856.
4. Yang F, Yin Y, Wang F etal. miR-17-5p Promotes migration of human hepatocellular carcinoma cells through the p38 mitogen-activated protein kinase-heat shock protein 27 pathway. Hepatology 2010; 51: 1614-1623.
5. Bai S, Nasser MW, Wang B etal. MicroRNA-122 inhibits tumorigenic properties of hepatocellular carcinoma cells and sensitizes these cells to sorafenib. J Biol Chem 2009; 284: 32015-32027.
6. Tsai WC, Hsu PW, Lai TC etal. MicroRNA-122, a tumor suppressor microRNA that regulates intrahepatic metastasis of hepatocellular carcinoma. Hepatology 2009; 49: 1571-1582.
7. Huang XH, Chen JS, Wang Q etal. miR-338-3p suppresses invasion of liver cancer cell by targeting smoothened. J Pathol 2011; 225: 463-472.
8. Huang XH, Wang Q, Chen JS etal. Bead-based microarray analysis of microRNA expression in hepatocellular carcinoma: miR-338 is downregulated. Hepatol Res 2009; 39: 786-794.
9. Chiyomaru T, Tatarano S, Kawakami K etal. SWAP70, actin-binding protein, function as an oncogene targeting tumor-suppressive miR-145 in prostate cancer. Prostate 2011; 25: doi: 10.1002/pros.21372
10. Arndt GM, Dossey L, Cullen LM etal. Characterization of global microRNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer. BMC Cancer 2009; 9: 374.
11. Kano M, Seki N, Kikkawa N etal. miR-145, miR-133a and miR-133b: tumor suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma. Int J Cancer 2010; 127: 2804-2814.
12. Larsson E, Fredlund Fuchs P, Heldin J etal. Discovery of microvascular miRNAs using public gene expression data: miR-145 is expressed in pericytes and is a regulator of Fli1. Genome Med 2009; 1: 108.
13. Sachdeva M, Mo YY. MicroRNA-145 suppresses cell invasion and metastasis by directly targeting mucin 1. Cancer Res 2010; 70: 378-387.
14. Chen JS, Huang XH, Wang Q etal. FAK is involved in invasion and metastasis of hepatocellular carcinoma. Clin Exp Metastasis 2010; 27: 71-82.
15. Chen Z, Zeng H, Guo Y etal. miRNA-145 inhibits non-small cell lung cancer cell proliferation by targeting c-Myc. J Exp Clin Cancer Res 2010; 29: 151.
16. Koo S, Martin GS, Schulz KJ etal. Serial selection for invasiveness increases expression of miR-143/miR-145 in glioblastoma cell lines. BMC Cancer 2012; 12: 143.
17. Shi B, Sepp-Lorenzino L, Prisco M etal. Micro RNA 145 targets the insulin receptor substrate-1 and inhibits the growth of colon cancer cells. J Biol Chem 2007; 282: 32582-32590.
18. Yoshimura T, Tomita T, Dixon MF etal. ADAMs (a disintegrin and metalloproteinase) messenger RNA expression in Helicobacter pylori-infected, normal, and neoplastic gastric mucosa. J Infect Dis 2002; 185: 332-340.
19. Zheng X, Jiang F, Katakowski M etal. ADAM17 promotes breast cancer cell malignant phenotype through EGFR-PI3K-AKT activation. Cancer Biol Ther 2009; 8: 1045-1054.
20. Ding X, Yang LY, Huang GW etal. ADAM17 mRNA expression and pathological features of hepatocellular carcinoma. World J Gastroenterol 2004; 10: 2735-2739.
21. Wildeboer D, Naus S, Amy Sang QX etal. etalloproteinase disintegrins ADAM8 and ADAM19 are highly regulated in human primary brain tumors and their expression levels and activities are associated with invasiveness. J Neuropathol Exp Neurol 2006; 65: 516-527.
22. Lemjabbar H, Li D, Gallup M etal. Tobacco smoke-induced lung cell proliferation mediated by tumor necrosis factor alpha-converting enzyme and amphiregulin. J Biol Chem 2003; 278: 26202-26207.
23. Borrell-Pages M, Rojo F, Albanell J etal. TACE is required for the activation of the EGFR by TGF-alpha in tumors. EMBO J 2003; 22: 1114-1124.